Skip to content
10-Q

Quarterly Report

G1 THERAPEUTICS, INC.

0001628280-23-035947

← back to feed
Filed
Nov 1, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Oct 27, 2023 51.84M sh
Shares Diluted Q3 2023 · Sep 30, 2023 51.78M sh
Shares Diluted Q3 2023 · Sep 30, 2023 51.7M sh
Shares Diluted Q3 2023 · Sep 30, 2022 42.8M sh
Shares Diluted Q3 2023 · Sep 30, 2022 42.73M sh
Capex Q3 2023 · Sep 30, 2023 $0
Capex Q3 2023 · Sep 30, 2022 $506K
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$25.55M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$97.99M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $52.62M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $94.59M
Stockholders Equity Q3 2023 · Sep 30, 2023 $43.02M
Stockholders Equity Q3 2023 · Jun 30, 2023 $57.55M
Stockholders Equity Q3 2023 · Mar 31, 2023 $44.99M
Stockholders Equity Q3 2023 · Dec 31, 2022 $68.75M
Stockholders Equity Q3 2023 · Sep 30, 2022 $45.97M
Stockholders Equity Q3 2023 · Jun 30, 2022 $66.33M
Stockholders Equity Q3 2023 · Mar 31, 2022 $100.13M
Stockholders Equity Q3 2023 · Dec 31, 2021 $143.54M
Current Liabilities Q3 2023 · Sep 30, 2023 $33.65M
Current Liabilities Q3 2023 · Dec 31, 2022 $35.59M
Total Liabilities Q3 2023 · Sep 30, 2023 $90.08M
Total Liabilities Q3 2023 · Dec 31, 2022 $119.22M
Current Assets Q3 2023 · Sep 30, 2023 $126.1M
Current Assets Q3 2023 · Dec 31, 2022 $179.5M
Total Assets Q3 2023 · Sep 30, 2023 $133.1M
Total Assets Q3 2023 · Dec 31, 2022 $187.97M
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.35
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.72
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.59
Eps Diluted Q3 2023 · Sep 30, 2022 −$2.67
Eps Basic Q3 2023 · Sep 30, 2023 −$0.35
Eps Basic Q3 2023 · Sep 30, 2023 −$0.72
Eps Basic Q3 2023 · Sep 30, 2022 −$0.59
Eps Basic Q3 2023 · Sep 30, 2022 −$2.67
Sga Expense Q3 2023 · Sep 30, 2023 $16.78M
Sga Expense Q3 2023 · Sep 30, 2023 $55.97M
Sga Expense Q3 2023 · Sep 30, 2022 $24.43M
Sga Expense Q3 2023 · Sep 30, 2022 $76.86M
Rd Expense Q3 2023 · Sep 30, 2023 $8.81M
Rd Expense Q3 2023 · Sep 30, 2023 $36.33M
Rd Expense Q3 2023 · Sep 30, 2022 $19.58M
Rd Expense Q3 2023 · Sep 30, 2022 $66.73M
Net Income Q3 2023 · Sep 30, 2023 −$18.2M
Net Income Q3 2023 · Sep 30, 2023 −$37.09M
Net Income Q3 2023 · Jun 30, 2023 $8.71M
Net Income Q3 2023 · Mar 31, 2023 −$27.6M
Net Income Q3 2023 · Sep 30, 2022 −$25.27M
Net Income Q3 2023 · Sep 30, 2022 −$113.91M
Net Income Q3 2023 · Jun 30, 2022 −$39.45M
Net Income Q3 2023 · Mar 31, 2022 −$49.19M
Operating Income Q3 2023 · Sep 30, 2023 −$16.37M
Operating Income Q3 2023 · Sep 30, 2023 −$30.6M
Operating Income Q3 2023 · Sep 30, 2022 −$21.55M
Operating Income Q3 2023 · Sep 30, 2022 −$105.29M
Revenue Q3 2023 · Sep 30, 2023 $12.3M
Revenue Q3 2023 · Sep 30, 2023 $67.64M
Revenue Q3 2023 · Sep 30, 2022 $23.58M
Revenue Q3 2023 · Sep 30, 2022 $41.05M